Stanford University
Showing 2,061-2,080 of 2,254 Results
-
Kevin K. Kumar, MD, PhD
Clinical Instructor, Neurosurgery
Affiliate, Neurosurgery OperationsBioDr. Kevin K. Kumar was born in New York City and grew up in Long Island, New York. He attended college at Cornell University where he majored in Biological Sciences with a concentration in Neurobiology and Behavior. After graduation, Dr. Kumar joined the Medical Scientist Training Program (MSTP) at Vanderbilt University to earn his combined MD/PhD. He completed his PhD in Neuroscience in the laboratory of Dr. Aaron Bowman, where he studied the regulation of manganese in both Parkinson’s and Huntington’s disease using high throughput screening, induced pluripotent stem cells, and untargeted metabolomics. He then began his neurosurgery residency at Stanford. As a resident, Dr. Kumar completed an NIH-funded postdoctoral fellowship in the laboratory of Dr. Marius Wernig in the Stanford Institute for Stem Cell Biology and Regenerative Medicine. His work focused on developing a platform to replace microglia in the brain as a novel therapy for neurodevelopmental disorders.
From 2023-2024, Dr. Kumar will serve as Clinical Instructor in Pediatric Neurosurgery at Lucile Packard Children’s Hospital at Stanford. In addition to his clinical duties, he will continue to advance cellular therapeutics for pediatric neurological diseases. -
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI work on imaging-guided therapy using PET and MR imaging approaches. My academic training and background is in molecular imaging. During my doctoral training, I developed and validated a PET imaging approach for evaluating endocrine therapy responses in advanced breast cancer. My current research focuses on imaging tumor immune markers and responses to cancer immunotherapy. The goal is to develop new imaging toolboxes to monitor and guide treatment. Specifically, I employ antibodies, nanoparticles, and reporter genes for imaging and combinations of therapies to modulate and restore the body's suppressed immune functions against cancer cells. This is being done in collaboration with teams of researchers in early clinical development and teams in clinical practice.
-
Parth I Kumar
Affiliate, Department Funds
Fellow in Graduate Medical EducationBioParth Kumar is a fellow in the Stanford University Nephrology Fellowship Program. Dr. Kumar holds a B.A. in Molecular and Cell Biology from UC Berkeley and an M.D. with Distinction from UCSF School of Medicine. He completed his Internal Medicine Residency at UC Irvine, where he was recognized as the Intern Teacher of the Year in 2022. Dr. Kumar's research interests span health care innovation and translational medicine, such as integrating 3D printing into clinical settings to aid patient education, evaluating novel medical devices. His past work includes the study "Evaluating the use of Radioactive Analogs of Doxorubicin for Quantifying ChemoFilter binding and Whole Body PET/MRI Biodistribution," leading to him being recognized as one of the JVIR Editor's Honorees: Distinguished Laboratory Investigations in 2022.
